Ophthalmology · Retina (Vascular Disorders, Detachment, Macular Disorders, Retinoblastoma)

In the DRS (Diabetic Retinopathy Study), the 'high-risk characteristics' (HRC) for severe visual loss that mandated immediate panretinal photocoagulation (PRP) included which combination?

  • A NVD > 1/3 disc area (DA), any vitreous hemorrhage, NVE > 1/2 DA with any hemorrhage
  • B NVD of any amount with preretinal or vitreous hemorrhage; NVD > 1/4-1/3 DA even without hemorrhage; NVE > 1/2 DA with preretinal or vitreous hemorrhage
  • C CSME with IRMA and NVE anywhere in the fundus without hemorrhage
  • D 4-2-1 rule: hemorrhage in 4 quadrants, IRMA in 2 quadrants, venous beading in 1 quadrant
Correct answer: B. NVD of any amount with preretinal or vitreous hemorrhage; NVD > 1/4-1/3 DA even without hemorrhage; NVE > 1/2 DA with preretinal or vitreous hemorrhage

Explanation

The DRS (Diabetic Retinopathy Study) defined high-risk characteristics (HRC) for severe visual loss (< 5/200 at 2+ follow-up visits) as: (1) neovascularization of the disc (NVD) ≥ 1/4 to 1/3 disc area, even without hemorrhage; (2) NVD of any size accompanied by preretinal or vitreous hemorrhage; and (3) neovascularization elsewhere (NVE) ≥ 1/2 disc area accompanied by preretinal or vitreous hemorrhage. Eyes with HRC had a 5-year severe visual loss risk of 26-37% without treatment, reduced to 11-20% with PRP. This established PRP as standard-of-care for high-risk PDR. The 4-2-1 rule (answer D) is from ETDRS and defines severe NPDR — predicting 50% conversion to PDR within 1 year.

Reference: Khurana Comprehensive Ophthalmology, 7th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Retina (Vascular Disorders, Detachment, Macular Disorders, Retinoblastoma) MCQs

See all Retina (Vascular Disorders, Detachment, Macular Disorders, Retinoblastoma) MCQs →